Tromboz, Gemostaz I Reologiya

Тромбоз, гемостаз и реология

Tromboz, Gemostaz I Reologiya
scientific and practical journal

ISSN 2078–1008 (Print); ISSN 2687-1483 (online)

Tromboz, Gemostaz I Reologiya

The journal «Tromboz, gemostaz I Reologiya» was founded in 2001 and is published 4 times per year. «Tromboz, gemostaz I Reologiya» is the official journal of Russian National Association of experts on thrombosis, clinical hemostasiology and hemorheology (www.hemostas.ru).

«Tromboz, gemostaz I Reologiya» is scientific and practical journal publishing reviews, original papers, case reports, etc. Published materials are devoted to diagnostics, therapy and prevention hemocoagulating and hemorheologic disorders owing to inherent or acquired reasons. Main topics are focused to thrombophilias, hemophilias, DIC, venous thromboembolism and thromboses as whole, atherosclerosis and atherothrombosis, platelets and vascular pathology, hemostasis genetics, fibrinolytic system, macro- and microrheologic blood properties, fibrin clot properties, relations between hemostasis system and blood rheology within human body, questions on hemostasis economy. Readers and subscribers have been informed constantly on new books, scientific forums and other professional events, etc.

«Tromboz, gemostaz I Reologiya» is a peer-reviewed journal with 2-years impact factor 0,886 indexed by eLIBRARY.

The journal rates at the SCOPUS database.

The  «TGR» has Q2 rating at Higher Attestation Commission list of periodicals which are recommended for publication of researches for applicants for scientific degrees.

Targetting.

The list of specialties for the journal "Tromboz, Gemostaz I Reologiya» (according to the HAC list dated 26.12.2019 (. pdf)
  • 3.3.3      Pathological physiology
  • 3.1.28    Hematology and Blood transfusion
  • 3.3.8      Clinical Laboratory Diagnostics
  • 3.1.12    Anesthesiology and Intensive Care
  • 3.1.24    Neurology
  • 3.1.4      Obstetrics and Gynecology
  • 3.1.6      Oncology, Radiation therapy
  • 3.1.20    Cardiology
  • 3.3.6      Pharmacology, Clinical Pharmacology
  • 3.1.27    Rheumatology
  • 3.1.8      Traumatology and Orthopedics
  • 3.1.21    Pediatrics

Main charts (Sections)

  • Original papers,
  • Clinical cases,
  • Lectures,
  • Reviews,
  • Professional news.

Options

Before publishing all materials have mandatory peer review.
For authors publications are free of charge.
The journal is citied by VINITI à The journal is cited VINITI.

The journal is included in the Russian index of Scientific Citation

Webpage: http://elibrary.ru/title_about.asp?id=26078 
Values (as per 2018)

The two-year impact factor = 0,543
The two-year impact factor with regard to the citation from all sources = 0,814
Ten-year h-index = 13,0

General information

  • Layout A4
  • Volume 80 pages
  • Quaterly
  • 1500 copies

Subscription

  • Per the editorial office
  • Per «Pressa Rossii» agency
    • 83835 - individual
    • 83837 - legal entities
  • Per JSC Russian Post
    • П18362 - individual
    • П18363 - legal entities
  • Per «Ural-Press» cataloque
    • 18362 - individual
    • 18363 - legal entities
  • Per alternative agencies catalogs

Distribution

Via mailing address.
Distribution at forums and exhibitions

The journal «Tromboz, gemostaz I Reologiya» registered by Federal service on supervision of legislation observance in sphere of mass communications and cultural heritage protection (August 24th, 2001; PI No. 779636).

The Editorial Board is not responsible for the content of advertisements. Under a reprint of materials the reference to the journal «Tromboz, gemostaz I Reologiya» is mandatory required.

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License

Review

Polina V. Osadchaya, Andrey A. Garanin, Anatolii O. Rubanenko
Raman spectroscopyin diagnosing hematological malignancies
Ivan R. Galak, Elena V. Fefelova, Namzhil N. Tsybikov
Quantitative, morphological, and functionalplatelet changes in iron deficiency anemia
Andrey Yu. Bulanov, Alexey V. Lyanguzov
Cryosupernatant transfusionas a possible means for correctingsepsis-induced coagulopathy
Marine M. Tanashyan, Eugene V. Roitman, Anton A. Raskurazhev, Polina I. Kuznetsova, Andrey S. Mazur
Thrombotic risk markers: рlasmin-α2‑antiplasmin complex

Original papers

Tatiana A. Andreeva, Olga E. Zalepukhinina, Valeriia N. Konstantinova, Inna A. Lavrichenko, Marina S. Leperova, Natalya N. Nikolaeva, Anton A. Kuchin, Natalia A. Arkhangelskaya
Adherence to emicizumab prophylaxisin patients with haemophilia A:results of the first single-centre study in Russia
Alexey N. Ivanov, Darya D. Loyko, Alexandra E. Lebedeva, Alena A. Rossoshanskaya, Tatyana V. Stepanova, Natalia A. Kuznetsova
Effects of the combinationof skin flap autologous transplantationand liraglutide on the vascular-platelet mechanismof hemostasis in white rats with absolute insulin deficiency
Nadezda A. Vorobyeva, Alexandra S. Vorontsova, Alexandra А. Murashkina
Hyperhomocysteinemia as a marker of acute stroke severity
Polina D. Duplyakova, Tatiana V. Pavlova, Dmitry V. Duplyakov
The Modified Fragility Index in patientswith myocardial infarction aged 90 years and older

Clinical cases

Kirill K. Noskov, Alexandra V. Bespalova, Taras A. Gritcenko, Ksenia V. Borisova, Igor L. Davydkin
Hereditary thrombophiliaand chronic demyelinating polyneuropathy:a clinical case
Elena L. Beliaeva, Andrei V. Koloskov, Olga I. Philippova, Kseniia A. Viutrikh, Ilana P. Tokareva, Valerii N. Marchenko
Crohn’s disease-associated coagulopathy
Alina G. Plisyuk, Grigoriy O. Dolgushin
Antithrombotic therapy optimizationin a patient with coronary heart diseaseand type 2 diabetes mellitus using the combinationof acetylsalicylic acid and rivaroxaban:a clinical case

Miscellaneous

Elena N. Parovichnikova, Vadim V. Ptushkin, Nadezhda I. Zozulya, Andrey N. Mamaev, Igor L. Davydkin, Tatiana I. Pospelova, Tatiana A. Mitina, Valeria N. Konstantinova, Alfiya F. Baybulatova, Petr Yu. Bochkarev, Ruslan O. Dreval, Rozi A. Teryan
Expert Council Resolution«Gene therapy for haemophilia B: a new reality»
Eugene V. Roitman
Does the Ministry of Health know what it recommends? Or Antithrombotic therapy in the latest editionof the Interim Guidelines «Prevention, diagnosis and treatment of new coronavirus infection (COVID‐19)»
View All Issues